|
GB884663A
(en)
|
1958-11-06 |
1961-12-13 |
Ciba Ltd |
New amines and processes for their manufacture
|
|
CH396941A
(de)
|
1959-08-10 |
1965-08-15 |
Ciba Geigy |
Verfahren zur Herstellung neuer sekundärer Amine
|
|
GB1200886A
(en)
|
1966-09-23 |
1970-08-05 |
Allen & Hanburys Ltd |
Phenylaminoethanol derivatives
|
|
US3509153A
(en)
|
1967-03-24 |
1970-04-28 |
Miles Lab |
5-phenyl (or 5-phenylalkyl)-2-(omega-(4-phenyl-1-piperazinyl)alkyl)tetrazoles
|
|
DE2710997C3
(de)
|
1977-03-14 |
1980-08-14 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
4-Alkoxy carbonylamino-phenyläthanolamine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US4569354A
(en)
|
1982-03-22 |
1986-02-11 |
Boston University |
Method and apparatus for measuring natural retinal fluorescence
|
|
ZA848004B
(en)
*
|
1983-10-19 |
1985-06-26 |
Hoffmann La Roche |
Phenoxypropanolamines
|
|
JPH0228112A
(ja)
|
1988-04-21 |
1990-01-30 |
Kaken Pharmaceut Co Ltd |
点眼用眼圧調整剤
|
|
US5135955A
(en)
|
1988-04-25 |
1992-08-04 |
Eli Lilly And Company |
Propanamine derivatives
|
|
IT1240427B
(it)
|
1990-03-02 |
1993-12-15 |
Ministero Dall Uni E Della Ric |
Arilpropilammine ad azione antifungina
|
|
DE69224861T2
(de)
|
1991-07-30 |
1998-08-06 |
Korea Res Inst Chem Tech |
Neue Phenylacetamidderivate und Verfahren zu ihrer Herstellung
|
|
WO1993015045A1
(en)
|
1992-01-29 |
1993-08-05 |
Smithkline Beecham Corporation |
N-(3-phenylpropyl)oxamic acid, oxamate, and oxamide derivatives
|
|
KR0155015B1
(ko)
*
|
1992-10-21 |
1998-12-01 |
고우야 마사시 |
2-아미노-1,3-프로판디올 화합물 및 면역 억제제
|
|
US5958973A
(en)
|
1993-09-03 |
1999-09-28 |
Gilead Sciences, Inc. |
Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors
|
|
BR9506549A
(pt)
|
1994-01-19 |
1997-10-14 |
Byk Nederland Bv |
Derivados de benzilamina contendo grupos nitróxi e sua aplicação para o tratamento de enfermidades cardiovasculares bem como de pressão interna dos olhos elevada
|
|
WO2001009327A2
(en)
|
1999-07-28 |
2001-02-08 |
Genentech, Inc. |
Method of preventing the injury or death of retinal cells and treating ocular diseases
|
|
US5541228A
(en)
|
1994-10-14 |
1996-07-30 |
Bristol-Myers Squibb Co. |
Melatonergic agents
|
|
US5693804A
(en)
*
|
1994-11-17 |
1997-12-02 |
Molecular Geriatrics Corporation |
Substituted 1-aryl-3-piperazin-1'-yl propanones
|
|
JPH0940646A
(ja)
*
|
1995-07-27 |
1997-02-10 |
Yamanouchi Pharmaceut Co Ltd |
ベンゼン縮合環誘導体又はその塩
|
|
US5641750A
(en)
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
|
|
US6090624A
(en)
|
1996-04-19 |
2000-07-18 |
Brown University Research Foundation |
Immortalized retinal cell lines and their applications
|
|
FR2747690B1
(fr)
|
1996-04-19 |
1998-06-12 |
Neurotech Sa |
Lignees immortalisees de cellules retiniennes et leurs applications au traitement de differents troubles primaires ou secondaires ophtalmologiques ou neurologiques
|
|
US6878544B2
(en)
|
1996-04-19 |
2005-04-12 |
Neurotech Sa |
Retinal cell lines with extended life-span and their applications
|
|
AUPO235996A0
(en)
|
1996-09-16 |
1996-10-10 |
Garvan Institute Of Medical Research |
Method of cell culture
|
|
CA2216439A1
(en)
|
1996-09-25 |
1998-03-25 |
Derek Van Der Kooy |
Pharmaceuticals containing retinal stem cells
|
|
DE19643592A1
(de)
|
1996-10-22 |
1998-04-23 |
Bayer Ag |
Verfahren zur Herstellung von alpha-Alkoxy-alpha-trifluormethyl-arylessigsäureestern und -arylessigsäuren
|
|
US6713300B1
(en)
|
1997-02-27 |
2004-03-30 |
University Of Utah Research Foundation |
Nucleic acid and amino acid sequences for ATP-binding cassette transporter and methods of screening for agents that modify ATP-binding cassette transporter
|
|
TW593331B
(en)
|
1997-07-25 |
2004-06-21 |
Inspire Pharmaceuticals Inc |
Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
|
|
US6051605A
(en)
|
1997-08-08 |
2000-04-18 |
Warner-Lambert Company |
Method of treating psychosis and schizophrenia
|
|
US6171837B1
(en)
|
1997-09-29 |
2001-01-09 |
The Trustees Of Columbia University In The City Of New York |
Mouse and human 9-cis-retinol dehydrogenase
|
|
WO1999029279A2
(en)
|
1997-12-05 |
1999-06-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Long-term survival and regeneration of central nervous system neurons
|
|
US6331537B1
(en)
|
1998-06-03 |
2001-12-18 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
|
|
KR20020013487A
(ko)
|
1999-01-05 |
2002-02-20 |
추후제출 |
성인 성상세포, 이의 제조방법 및 용도
|
|
EP1107003A1
(en)
|
1999-12-09 |
2001-06-13 |
Trophos |
Methods for screening compounds active on neurons
|
|
US6406840B1
(en)
|
1999-12-17 |
2002-06-18 |
Biomosaic Systems, Inc. |
Cell arrays and the uses thereof
|
|
WO2001046195A1
(en)
|
1999-12-21 |
2001-06-28 |
Gpi Nil Holdings, Inc. |
Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
|
|
WO2001053297A1
(en)
*
|
2000-01-20 |
2001-07-26 |
Merck & Co., Inc. |
Alpha v integrin receptor antagonists
|
|
AU2001264564A1
(en)
|
2000-05-02 |
2001-11-12 |
Central Institute For The Deaf |
Composition and methods for treating photoreceptor degeneration
|
|
US20020009713A1
(en)
|
2000-05-11 |
2002-01-24 |
Miller Freda D. |
Methods for identifying modulators of neuronal growth
|
|
CZ200350A3
(cs)
*
|
2000-07-13 |
2003-05-14 |
Sankyo Company Limited |
Aminoalkoholové deriváty
|
|
JP2002167382A
(ja)
*
|
2000-07-13 |
2002-06-11 |
Sankyo Co Ltd |
アミノアルコ−ル誘導体
|
|
JP2002053575A
(ja)
*
|
2000-08-09 |
2002-02-19 |
Sankyo Co Ltd |
アミノアルコ−ル類
|
|
US20030032078A1
(en)
|
2001-01-23 |
2003-02-13 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the treatment of macular and retinal degenerations
|
|
DE10141018A1
(de)
|
2001-08-22 |
2003-03-13 |
Eth Zuerich Eidgenoessische Te |
Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
|
|
MXPA04006709A
(es)
*
|
2002-01-11 |
2004-10-04 |
Sankyo Co |
Derivados de aminoalcohol o derivados de acido fosfonico y composiciones farmaceuticas que los contienen.
|
|
JP4771511B2
(ja)
*
|
2003-07-08 |
2011-09-14 |
第一三共株式会社 |
アミノアルコ−ル誘導体又はホスホン酸誘導体を含有する医薬組成物
|
|
EP1551956A4
(en)
|
2002-07-12 |
2006-12-27 |
Univ Washington |
METHOD AND SYSTEMS FOR THE EXTENDED IN VITRO CULTURE OF NEURONAL CELLS
|
|
DE10235312A1
(de)
|
2002-08-01 |
2004-02-12 |
Basf Ag |
Verfahren zur Herstellung von Aminoalkoxybenzylaminen und Aminoalkoxybenzonitrilen als Zwischenprodukte
|
|
MXPA05005240A
(es)
|
2002-12-06 |
2005-07-25 |
Alcon Inc |
Imitadores de la superoxido - dismutasa para el tratamiento de desordenes y enfermedades oculares.
|
|
AU2004216898A1
(en)
*
|
2003-03-04 |
2004-09-16 |
Pfizer Products Inc. |
Use of EP2 selective receptor agonists in medical treatment
|
|
US20060281821A1
(en)
|
2003-03-14 |
2006-12-14 |
Krzysztof Palczewski |
Retinoid replacements and opsin agonists and methods for the use thereof
|
|
EP1649009A2
(en)
|
2003-07-30 |
2006-04-26 |
Acucela, Inc. |
Extended primary retinal cell culture and stress models, and methods of use
|
|
AU2004268455B2
(en)
|
2003-08-29 |
2009-12-17 |
Ono Pharmaceutical Co., Ltd. |
Compound capable of binding S1P receptor and pharmaceutical use thereof
|
|
US7706863B2
(en)
|
2004-01-21 |
2010-04-27 |
University Of Washington |
Methods for assessing a physiological state of a mammalian retina
|
|
US7566808B2
(en)
|
2004-02-17 |
2009-07-28 |
President And Fellows Of Harvard College |
Management of ophthalmologic disorders, including macular degeneration
|
|
JP4242911B2
(ja)
*
|
2004-08-26 |
2009-03-25 |
ファイザー・インク |
プロテインキナーゼ阻害薬としてのエナンチオピュアなアミノヘテロアリール化合物
|
|
TWI359810B
(en)
|
2004-11-04 |
2012-03-11 |
Mitsubishi Tanabe Pharma Corp |
Carboxylic acid derivative containing thiazole rin
|
|
WO2006091796A2
(en)
|
2005-02-22 |
2006-08-31 |
Acucela, Inc. |
Compositions and methods for diagnosing and treating retinal diseases
|
|
CN101193878A
(zh)
*
|
2005-03-22 |
2008-06-04 |
协和发酵工业株式会社 |
实体肿瘤治疗剂
|
|
US8098907B2
(en)
|
2005-07-01 |
2012-01-17 |
Siemens Corporation |
Method and system for local adaptive detection of microaneurysms in digital fundus images
|
|
TW200744567A
(en)
|
2005-09-23 |
2007-12-16 |
Alcon Inc |
Phenylethylamine analogs and their use for treating glaucoma
|
|
EP1948652B1
(en)
*
|
2005-11-01 |
2011-08-24 |
Array Biopharma, Inc. |
Glucokinase activators
|
|
US7622496B2
(en)
*
|
2005-12-23 |
2009-11-24 |
Zealand Pharma A/S |
Modified lysine-mimetic compounds
|
|
CA2636601C
(en)
|
2006-01-13 |
2019-03-19 |
Cosmas Therapeutics Development Inc. |
Novel melatonin ligands having antidepressant activity as well as sleep inducing properties
|
|
US20070293548A1
(en)
|
2006-03-31 |
2007-12-20 |
Wang Eric Y |
Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
|
|
CA2648804C
(en)
*
|
2006-04-07 |
2014-05-27 |
Methylgene Inc. |
Benzamide derivatives as inhibitors of histone deacetylase
|
|
EP2019837B1
(en)
*
|
2006-05-23 |
2011-03-23 |
Irm Llc |
Compounds and compositions as channel activating protease inhibitors
|
|
CN101534833B
(zh)
*
|
2006-07-18 |
2013-03-13 |
贝塞斯达药理学联合有限责任公司 |
烟碱脱敏剂及选择、测试及使用它们的方法
|
|
AU2007280130B2
(en)
*
|
2006-07-28 |
2011-09-22 |
Pfizer Products Inc. |
EP2 agonists
|
|
MX2009011360A
(es)
|
2007-04-20 |
2010-02-12 |
Acucela Inc |
Compuestos derivados de estirenilo para tratar enfermedades y trastornos oftalmicos.
|
|
TW200906389A
(en)
|
2007-05-25 |
2009-02-16 |
Daiichi Sankyo Co Ltd |
Pharmaceutical composition comprising of therapeutic or prophylactic agents for hepatitis
|
|
NZ601866A
(en)
|
2007-06-29 |
2013-12-20 |
Acucela Inc |
Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
|
|
US7973079B2
(en)
*
|
2007-09-27 |
2011-07-05 |
Revision Therapeutics, Inc. |
Methods and compounds for treating retinol-related diseases
|
|
MX2010003667A
(es)
*
|
2007-10-05 |
2010-09-28 |
Acucela Inc |
Compuestos alcoxi para el tratamiento de enfermedades.
|
|
CN101835777A
(zh)
*
|
2007-10-25 |
2010-09-15 |
尔察祯有限公司 |
碳头孢烯β-内酰胺抗生素
|
|
AR070950A1
(es)
|
2007-11-01 |
2010-05-19 |
Acucela Inc |
Compuestos derivados de amina, composiciones farmaceuticas de ellos, compuestos inhibidores de produccion de 11-cis-retinol y metodos para tratar enfermedades y trastornos oftalmicos
|
|
WO2009113637A1
(ja)
*
|
2008-03-12 |
2009-09-17 |
東ソー株式会社 |
新規なチアゾール誘導体、チアゾール誘導体固定化マトリックス、及びそれらの製造方法
|
|
KR101395952B1
(ko)
|
2008-09-05 |
2014-05-21 |
어큐셀라 인코포레이티드 |
안과 질환 및 장애 치료를 위한 황-연결 화합물
|
|
BRPI0919920A2
(pt)
|
2008-10-22 |
2016-02-16 |
Acucela Inc |
compostos para tratamento de doenças e desordens oftálmicas
|
|
ES2897527T3
(es)
|
2009-07-02 |
2022-03-01 |
Acucela Inc |
Farmacología de moduladores del ciclo visual
|
|
GB2474120B
(en)
|
2009-10-01 |
2011-12-21 |
Amira Pharmaceuticals Inc |
Compounds as Lysophosphatidic acid receptor antagonists
|
|
EP2804605A4
(en)
|
2012-01-20 |
2015-07-08 |
Acucela Inc |
SUBSTITUTED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASES
|
|
TW201406707A
(zh)
|
2012-05-04 |
2014-02-16 |
Acucela Inc |
用以治療糖尿病性視網膜病變及其他眼部疾病之方法
|